论文部分内容阅读
目的:观察急性呼吸窘迫综合征临床治疗效果,并对预后影响因素进行分析。方法:回顾性分析2006年3月~2011年10月在我院接受治疗的56例急性呼吸窘迫综合征患者的临床资料,使用SPSS12.0进行统计分析,并进行多因素Logistic回归分析。结果:采用以PEEP为主的综合治疗,并联合使用血必净注射液和乌司他丁,治疗ARDS病死率为26.8%;预后影响因素中ARDS并发MODS、APACHEⅡ评分和发病至接受治疗时间具有显著意义。结论:该治疗方法病死率较低,效果良好;ARDS并发并发MODS、APACHEⅡ评分和发病至接受治疗时间是影响ARDS患者的病死预后主要因素。
Objective: To observe the clinical effect of acute respiratory distress syndrome and to analyze the prognostic factors. Methods: The clinical data of 56 patients with acute respiratory distress syndrome treated in our hospital from March 2006 to October 2011 were retrospectively analyzed. The data were analyzed by SPSS12.0 and multivariate Logistic regression analysis. Results: The PEEP-based combination therapy combined with Xuebijing injection and ulinastatin treatment of ARDS mortality was 26.8%; ARDS complicated with MODS, APACHE Ⅱ score and the time from onset to treatment of prognostic factors Significant. Conclusions: The mortality of this treatment is lower and the effect is good. Concurrent MODS, APACHEⅡscore and the time from onset to treatment of ARDS are the main factors affecting the prognosis of ARDS patients.